Introduction:Basic information about CAS 851881-60-2|ADX-47273, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | ADX-47273 |
|---|
| CAS Number | 851881-60-2 | Molecular Weight | 369.365 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 540.8±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C20H17F2N3O2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 280.9±32.9 °C |
|---|
Names
| Name | (4-fluorophenyl)-[(3S)-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methanone |
|---|
| Synonym | More Synonyms |
|---|
ADX-47273 BiologicalActivity
| Description | ADX-47273 is a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR5(EC50=170 nM).IC50 value: 170 nM(EC50) [1] [2]Target: positive allosteric modulator (PAM) of mGluR5in vitro: ADX-47273 increased (9-fold) the response to threshold concentration of glutamate (50 nM) in fluorometric Ca(2+) assays (EC(50) = 170 nM) in human embryonic kidney 293 cells expressing rat mGlu5. ADX47273 dose-dependently shifted mGlu5 receptor glutamate response curve to the left (9-fold at 1 microM) and competed for binding of [(3)H]2-methyl-6-(phenylethynyl)pyridine (K(i) = 4.3 microM), but not [(3)H]quisqualate [2]. in vivo: ADX47273 increased extracellular signal-regulated kinase and cAMP-responsive element-binding protein phosphorylation in hippocampus and prefrontal cortex, both of which are critical for glutamate-mediated signal transduction mechanisms. In models sensitive to antipsychotic drug treatment, ADX47273 reduced rat-conditioned avoidance responding [minimal effective dose (MED) = 30 mg/kg i.p.] and decreased mouse apomorphine-induced climbing (MED = 100 mg/kg i.p.), with little effect on stereotypy or catalepsy [2]. ADX47273 had no effect on single-session and multi-session extinction, but administration of ADX47273 after a single retrieval trial enhanced subsequent fear extinction learning [3]. |
|---|
| Related Catalog | Research Areas >>Neurological Disease |
|---|
| References | [1]. de Paulis T, et al. Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes. J Med Chem. 2006 Jun 1;49(11):3332-44. [2]. Liu F, et al. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J Pharmacol Exp Ther. 2008 Dec;327(3):827-39. [3]. Xu J, et al. Potentiating mGluR5 function with a positive allosteric modulator enhances adaptive learning. Learn Mem. 2013 Jul 18;20(8):438-45. |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 540.8±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C20H17F2N3O2 |
|---|
| Molecular Weight | 369.365 |
|---|
| Flash Point | 280.9±32.9 °C |
|---|
| Exact Mass | 369.128876 |
|---|
| PSA | 59.23000 |
|---|
| LogP | 3.48 |
|---|
| Appearance of Characters | white solid |
|---|
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
|---|
| Index of Refraction | 1.580 |
|---|
| InChIKey | VXQCCZHCFBHTTD-HNNXBMFYSA-N |
|---|
| SMILES | O=C(c1ccc(F)cc1)N1CCCC(c2nc(-c3ccc(F)cc3)no2)C1 |
|---|
| Storage condition | -20℃ |
|---|
Synonyms
| UNII-4C4P7L0W63 |
| (4-Fluorophenyl){(3S)-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl}methanone |
| cc-252 |
| Methanone, (4-fluorophenyl)[(3S)-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]- |
| ADX-47273 |
| ADX 47273 |